Skip to main content

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
+2 vs. Q3 2023
Shares held
9.15M
+248.4K (+2.8%) vs. Q3 2023
Total value
$16.5M
+$4.28M (+35.1%) vs. Q3 2023
New holders
5
7 more added
Sold out
3
7 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 29 institutions
Q1 2021: 34 institutionsQ2 2021: 34 institutionsQ3 2021: 35 institutionsQ4 2021: 36 institutionsQ1 2022: 32 institutionsQ2 2022: 31 institutionsQ3 2022: 31 institutionsQ4 2022: 28 institutionsQ1 2023: 30 institutionsQ2 2023: 33 institutionsQ3 2023: 28 institutionsQ4 2023: 29 institutionsQ1 2024: 29 institutionsQ2 2024: 32 institutionsQ3 2024: 33 institutionsQ4 2024: 75 institutionsQ1 2025: 83 institutionsQ2 2025: 85 institutionsQ3 2025: 83 institutionsQ4 2025: 95 institutionsQ1 2026: 121 institutionsQ2 2026: 161 institutions
Value heldQ4 2023: $16.5M
Q1 2021: $89.0MQ2 2021: $74.5MQ3 2021: $52.1MQ4 2021: $34.7MQ1 2022: $27.6MQ2 2022: $15.9MQ3 2022: $17.3MQ4 2022: $14.4MQ1 2023: $14.7MQ2 2023: $12.7MQ3 2023: $12.2MQ4 2023: $16.5MQ1 2024: $19.8MQ2 2024: $48.2MQ3 2024: $46.0MQ4 2024: $158.5MQ1 2025: $130.3MQ2 2025: $110.7MQ3 2025: $94.5MQ4 2025: $66.7MQ1 2026: $131.2MQ2 2026: $184.6M
Institutions holding ELDN and their total value by quarter
QuarterHoldersValue
Q2 2026161$184.6M
Q1 2026121$131.2M
Q4 202595$66.7M
Q3 202583$94.5M
Q2 202585$110.7M
Q1 202583$130.3M
Q4 202475$158.5M
Q3 202433$46.0M
Q2 202432$48.2M
Q1 202429$19.8M
Q4 202329$16.5M
Q3 202328$12.2M
Q2 202333$12.7M
Q1 202330$14.7M
Q4 202228$14.4M
Q3 202231$17.3M
Q2 202231$15.9M
Q1 202232$27.6M
Q4 202136$34.7M
Q3 202135$52.1M
Q2 202134$74.5M
Q1 202134$89.0M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2023.

Institutions holding ELDN in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc4,326,710$7.79M0.19%00.0%Unchanged
Armistice Capital, LLC2,189,000$3.94M0.10%+365,000+20.0%Added
Vanguard Group Inc695,418$1.25M0.00%+20,898+3.1%Added
Woodline Partners LP689,340$1.24M0.01%+85,347+14.1%Added
Ensign Peak Advisors, Inc443,001$797.4K0.00%00.0%Unchanged
Geode Capital Management, LLC176,039$317.0K0.00%00.0%Unchanged
CM Management, LLC140,000$252.0K0.20%−94,803−40.4%Reduced
Susquehanna International Group, LLP86,323$155.4K0.00%+29,747+52.6%Added
Renaissance Technologies LLC69,173$125.0K0.00%+7,200+11.6%Added
Jmac Enterprises LLC58,041$104.5K0.02%00.0%Unchanged
Ingalls & Snyder LLC51,849$93.0K0.00%00.0%Unchanged
State Street Corp44,692$80.4K0.00%00.0%Unchanged
Northern Trust Corp39,900$71.8K0.00%−7,528−15.9%Reduced
BlackRock Inc.28,302$50.9K0.00%00.0%Unchanged
Citadel Advisors LLC23,208$41.8K0.00%+23,208New
Millennium Management LLC22,867$41.2K0.00%−4,283−15.8%Reduced
Mercer Global Advisors Inc16,726$30.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc14,987$27.0K0.00%00.0%Unchanged
Pathstone Holdings, LLC13,029$23.5K0.00%+13,029New
Two Sigma Securities, LLC11,780$21.2K0.00%+11,780New
Tower Research Capital LLC (TRC)5,636$10.1K0.00%−2,807−33.2%Reduced
Simplex Trading, LLC3,223$5.00K0.00%−400−11.0%Reduced
Morgan Stanley2,155$3.88K0.00%00.0%Unchanged
JPMorgan Chase & Co990$1.78K0.00%+964+3,707.7%Added
UBS Group AG556$1.00K0.00%+556New
Wells Fargo & Company186$3350.00%+14+8.1%Added
Group One Trading, L.P.22$400.00%−4,828−99.5%Reduced
Bank of America Corp15$270.00%+15New
Royal Bank of Canada108$00.00%−158,099−99.9%Reduced
SVB Financial Group0$00.00%−13,472−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−13,100−100.0%Sold out
RMB Capital Management, LLC0$00.00%−10,000−100.0%Sold out
Pathstone Family Office, LLC––––Not filed